In this study, we explored a neuroprotective strategy focused on preserving neuronal bioenergetics, based on the hypothesis that defects in Glut metabolism are interconnected ends of a dysfunctional axis along which PD cell damage progresses. This evidence concerns the gene SLC2A1 and Parkinson disease.